{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,29]],"date-time":"2026-05-29T20:17:15Z","timestamp":1780085835222,"version":"3.54.0"},"reference-count":60,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,10,5]],"date-time":"2025-10-05T00:00:00Z","timestamp":1759622400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.es","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neurolog\u00eda (English Edition)"],"published-print":{"date-parts":[[2025,11]]},"DOI":"10.1016\/j.nrleng.2025.10.006","type":"journal-article","created":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T02:18:03Z","timestamp":1760062683000},"page":"864-874","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Impact of fatigue on quality of life in adults with multiple sclerosis"],"prefix":"10.1016","volume":"40","author":[{"given":"R.","family":"Pi\u00f1ar-Morales","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.A.","family":"Guirado-Ruiz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.J.","family":"Barrero Hern\u00e1ndez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"8","key":"10.1016\/j.nrleng.2025.10.006_bib0005","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1001\/jama.2020.26858","article-title":"Diagnosis and treatment of multiple sclerosis: a review","volume":"325","author":"McGinley","year":"2021","journal-title":"JAMA"},{"issue":"2","key":"10.1016\/j.nrleng.2025.10.006_bib0010","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/j.ncl.2010.12.007","article-title":"Individual and joint action of environmental factors and risk of MS","volume":"29","author":"Van der Mei","year":"2011","journal-title":"Neurol Clin"},{"issue":"2","key":"10.1016\/j.nrleng.2025.10.006_bib0015","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1056\/NEJMra1401483","article-title":"Multiple sclerosis","volume":"378","author":"Reich","year":"2018","journal-title":"N Engl J Med"},{"key":"10.1016\/j.nrleng.2025.10.006_bib0020","article-title":"Therapeutic advances in multiple sclerosis","volume":"13","author":"Yang","year":"2022","journal-title":"Front Neurol"},{"issue":"4","key":"10.1016\/j.nrleng.2025.10.006_bib0025","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0123824","article-title":"Long-term persistence with injectable therapy in relapsing-remitting multiple sclerosis: an 18-year observational cohort study","volume":"10","author":"Zhornitsky","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.nrleng.2025.10.006_bib0030","series-title":"Fatigue and multiple sclerosis: evidence-based management strategies for fatigue in multiple sclerosis","year":"1998"},{"issue":"4","key":"10.1016\/j.nrleng.2025.10.006_bib0035","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1191\/135248506ms1373ed","article-title":"Fatigue is intrinsic to multiple sclerosis (MS) and is the most commonly reported symptom of the disease","volume":"12","author":"Krupp","year":"2006","journal-title":"Mult Scler"},{"issue":"1","key":"10.1016\/j.nrleng.2025.10.006_bib0040","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1136\/jnnp.2005.074948","article-title":"Multiple sclerosis related fatigue","volume":"77","author":"Giovannoni","year":"2006","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.nrleng.2025.10.006_bib0045","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1177\/1545968306298934","article-title":"Origin of fatigue in multiple sclerosis: review of the literature","volume":"22","author":"Kos","year":"2008","journal-title":"Neurorehabil Neural Repair"},{"issue":"8","key":"10.1016\/j.nrleng.2025.10.006_bib0050","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1093\/sleep\/33.8.1061","article-title":"Fatigue in multiple sclerosis: mechanisms, evaluation, and treatment","volume":"33","author":"Braley","year":"2010","journal-title":"Sleep"},{"issue":"1","key":"10.1016\/j.nrleng.2025.10.006_bib0055","article-title":"Quality of life in multiple sclerosis: the differential impact of motor and cognitive fatigue","volume":"7","author":"David Ruban","year":"2021","journal-title":"Mult Scler J Exp Transl Clin"},{"issue":"10","key":"10.1016\/j.nrleng.2025.10.006_bib0060","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1001\/archneur.1989.00520460115022","article-title":"The fatigue severity scale. Application to patients with multiple sclerosis and systemic lupus erythematosus","volume":"46","author":"Krupp","year":"1989","journal-title":"Arch Neurol"},{"issue":"27","key":"10.1016\/j.nrleng.2025.10.006_bib0065","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3310\/hta4270","article-title":"Treatments for fatigue in multiple sclerosis: a rapid and systematic review","volume":"4","author":"Bra\u00f1as","year":"2000","journal-title":"Health Technol Assess"},{"issue":"1","key":"10.1016\/j.nrleng.2025.10.006_bib0070","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.jpsychores.2008.05.003","article-title":"The psychology of fatigue in patients with multiple sclerosis: a review","volume":"66","author":"Bol","year":"2009","journal-title":"J Psychosom Res"},{"key":"10.1016\/j.nrleng.2025.10.006_bib0075","doi-asserted-by":"crossref","DOI":"10.3389\/fneur.2021.817256","article-title":"Co-occurrence of Fatigue and depression in people with multiple sclerosis: a mini-review","volume":"12","author":"Tarasiuk","year":"2022","journal-title":"Front Neurol"},{"issue":"9","key":"10.1016\/j.nrleng.2025.10.006_bib0080","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1038\/nrneurol.2014.139","article-title":"The link between multiple sclerosis and depression","volume":"10","author":"Feinstein","year":"2014","journal-title":"Nat Rev Neurol"},{"key":"10.1016\/j.nrleng.2025.10.006_bib0085","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1097\/MRR.0b013e32834ad479","article-title":"Quality of life in patients with multiple sclerosis: the impact of depression, fatigue, and disability","volume":"34","author":"G\u00f6ksel Karatepe","year":"2011","journal-title":"Int J Rehabil Res"},{"key":"10.1016\/j.nrleng.2025.10.006_bib0090","doi-asserted-by":"crossref","first-page":"1524","DOI":"10.1212\/01.WNL.0000095964.34294.B4","article-title":"Major depression in multiple sclerosis: a population-based perspective","volume":"61","author":"Patten","year":"2003","journal-title":"Neurology"},{"issue":"Suppl. 200","key":"10.1016\/j.nrleng.2025.10.006_bib0095","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1111\/ane.12648","article-title":"Fatigue and depression in multiple sclerosis: pharmacological and non- pharmacological interventions","volume":"134","author":"Brenner","year":"2016","journal-title":"Acta Neurol Scand"},{"issue":"1\u20132","key":"10.1016\/j.nrleng.2025.10.006_bib0100","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.jns.2005.11.025","article-title":"Fatigue in multiple sclerosis is related to disability, depression and quality of life","volume":"243","author":"Pittion-Vouyovitch","year":"2006","journal-title":"J Neurol Sci"},{"key":"10.1016\/j.nrleng.2025.10.006_bib0105","doi-asserted-by":"crossref","first-page":"496","DOI":"10.4414\/smw.2007.11874","article-title":"Cognition, mood and fatigue in patients in the early stage of multiple sclerosis","volume":"137","author":"Simioni","year":"2007","journal-title":"Swiss Med Wkly"},{"key":"10.1016\/j.nrleng.2025.10.006_bib0110","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1177\/135245850100700511","article-title":"Quality of life in multiple sclerosis: the impact of depression, fatigue and disability","volume":"7","author":"Amato","year":"2001","journal-title":"Mult Scler"},{"issue":"1","key":"10.1016\/j.nrleng.2025.10.006_bib0115","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/S0022-510X(02)00312-X","article-title":"Quality of life in patients with multiple sclerosis: the impact of fatigue and depression","volume":"205","author":"Janardhan","year":"2002","journal-title":"J Neurol Sci"},{"key":"10.1016\/j.nrleng.2025.10.006_bib0120","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1186\/1471-2458-13-224","article-title":"Work capacity and health-related quality of life among individuals with multiple sclerosis reduced by fatigue: a cross-sectional study","volume":"13","author":"Flensner","year":"2013","journal-title":"BMC Public Health"},{"key":"10.1016\/j.nrleng.2025.10.006_bib0125","doi-asserted-by":"crossref","first-page":"373","DOI":"10.2147\/PROM.S168095","article-title":"Dimethyl fumarate in the treatment of relapsing-remitting multiple sclerosis: patient reported outcomes and perspectives","volume":"10","author":"Ozel","year":"2019","journal-title":"Patient Relat Outcome Meas"},{"issue":"1\u20132","key":"10.1016\/j.nrleng.2025.10.006_bib0130","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1159\/000447630","article-title":"Fatigue improvement after switching multiple sclerosis treatment from interferon-\u03b2 to glatiramer acetate in clinical practice","volume":"76","author":"Meca-Lallana","year":"2016","journal-title":"Eur Neurol"},{"key":"10.1016\/j.nrleng.2025.10.006_bib0135","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1016\/j.eurpsy.2005.09.013","article-title":"Psychiatric side effects of interferon-beta in multiple sclerosis","volume":"21","author":"Goeb","year":"2006","journal-title":"Eur Psychiatry"},{"key":"10.1016\/j.nrleng.2025.10.006_bib0140","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/j.msard.2017.07.008","article-title":"Systematic review of depression in patients with multiple sclerosis and its relationship to interferonb treatment","volume":"17","author":"Alba Pal\u00e9","year":"2017","journal-title":"Mult Scler Relat Disord"},{"issue":"5","key":"10.1016\/j.nrleng.2025.10.006_bib0145","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1177\/1352458517690824","article-title":"The Nine-Hole Peg Test as a manual dexterity performance measure for multiple sclerosis","volume":"23","author":"Feys","year":"2017","journal-title":"Mult Scler"},{"issue":"2","key":"10.1016\/j.nrleng.2025.10.006_bib0150","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1177\/13524585211017013","article-title":"The timed 25-foot walk in a large cohort of multiple sclerosis patients","volume":"28","author":"Kalinowski","year":"2022","journal-title":"Mult Scler"},{"key":"10.1016\/j.nrleng.2025.10.006_bib0155","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1191\/1352458502ms839oa","article-title":"Fatigue in multiple sclerosis: a comparison of different rating scales and correlation to clinical parameter","volume":"8","author":"Flachenecker","year":"2002","journal-title":"Mult Scler"},{"key":"10.1016\/j.nrleng.2025.10.006_bib0160","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1001\/archpsyc.1961.01710120031004","article-title":"An inventory for measuring depression","volume":"4","author":"Beck","year":"1961","journal-title":"Arch Gen Psychiatry"},{"issue":"13","key":"10.1016\/j.nrleng.2025.10.006_bib0165","doi-asserted-by":"crossref","first-page":"1781","DOI":"10.1177\/1352458518808204","article-title":"Symbol Digit Modalities Test: a valid clinical trial endpoint for measuring cognition in multiple sclerosis","volume":"25","author":"Strober","year":"2019","journal-title":"Mult Scler"},{"issue":"3","key":"10.1016\/j.nrleng.2025.10.006_bib0170","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/0168-8510(90)90421-9","article-title":"EuroQol\u2014a new facility for the measurement of health-related quality of life","volume":"16","year":"1990","journal-title":"Health Policy"},{"key":"10.1016\/j.nrleng.2025.10.006_bib0175","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1177\/1352458508097466","article-title":"Longitudinal correlates of fatigue in multiple sclerosis","volume":"15","author":"Patrick","year":"2009","journal-title":"Mult Scler"},{"issue":"2","key":"10.1016\/j.nrleng.2025.10.006_bib0180","doi-asserted-by":"crossref","first-page":"71","DOI":"10.7224\/1537-2073.2015-013","article-title":"Associations between fatigue and disability, functional mobility, depression, and quality of life in people with multiple sclerosis","volume":"18","author":"Garg","year":"2016","journal-title":"Int J MS Care"},{"key":"10.1016\/j.nrleng.2025.10.006_bib0185","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1016\/j.msard.2019.01.011","article-title":"Prevalence of fatigue and its association with clinical features in progressive and non-progressive forms of Multiple Sclerosis","volume":"28","author":"Rooney","year":"2019","journal-title":"Mult Scler Relat Disord"},{"issue":"5","key":"10.1016\/j.nrleng.2025.10.006_bib0190","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1191\/1352458503ms943oa","article-title":"Fatigue and its association with sociodemographic variables among multiple sclerosis patients","volume":"9","author":"Lerdal","year":"2003","journal-title":"Mult Scler J"},{"key":"10.1016\/j.nrleng.2025.10.006_bib0195","doi-asserted-by":"crossref","DOI":"10.1016\/j.msard.2021.102799","article-title":"Associations between fatigue impact and lifestyle factors in people with multiple sclerosis - the Danish MS hospitals rehabilitation study","volume":"50","author":"Johansson","year":"2021","journal-title":"Mult Scler Relat Disord"},{"issue":"1","key":"10.1016\/j.nrleng.2025.10.006_bib0200","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1007\/s13167-019-00191-0","article-title":"Vitamin D deficiency and its association with fatigue and quality of life in multiple sclerosis patients","volume":"11","author":"Beckmann","year":"2020","journal-title":"EPMA J"},{"issue":"2","key":"10.1016\/j.nrleng.2025.10.006_bib0205","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1191\/1352458505ms1148oa","article-title":"Does the Modified Fatigue Impact Scale offer a more comprehensive assessment of fatigue in MS?","volume":"11","author":"T\u00e9llez","year":"2005","journal-title":"Mult Scler"},{"issue":"2","key":"10.1016\/j.nrleng.2025.10.006_bib0210","doi-asserted-by":"crossref","first-page":"96","DOI":"10.7224\/1537-2073.2015-070","article-title":"Fatigue and comorbidities in multiple sclerosis","volume":"18","author":"Fiest","year":"2016","journal-title":"Int J MS Care"},{"key":"10.1016\/j.nrleng.2025.10.006_bib0215","article-title":"Psychometric properties of the Fatigue Severity Scale and the Modified Fatigue Impact Scale","volume":"3","author":"Learmonth","year":"2013","journal-title":"J Neurol Sci"},{"issue":"2","key":"10.1016\/j.nrleng.2025.10.006_bib0220","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1177\/1352458512450351","article-title":"Prevalence and concurrence of anxiety, depression and fatigue over time in multiple sclerosis","volume":"19","author":"Wood","year":"2013","journal-title":"Mult Scler"},{"issue":"7","key":"10.1016\/j.nrleng.2025.10.006_bib0225","doi-asserted-by":"crossref","first-page":"1148","DOI":"10.1016\/j.bbi.2010.05.006","article-title":"Correlates of cognitive dysfunction in multiple sclerosis","volume":"24","author":"Heesen","year":"2010","journal-title":"Brain Behav Immun"},{"key":"10.1016\/j.nrleng.2025.10.006_bib0230","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1177\/135245850000600308","article-title":"Fatigue in multiple sclerosis and its relationship to depression and neurologic disability","volume":"6","author":"Bakshi","year":"2000","journal-title":"Mult Scler"},{"issue":"2","key":"10.1016\/j.nrleng.2025.10.006_bib0235","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1177\/135245850000600213","article-title":"Fatigue in multiple sclerosis: relationship to depression, disability, and disease pattern","volume":"6","author":"Kroencke","year":"2000","journal-title":"Mult Scler"},{"issue":"7","key":"10.1016\/j.nrleng.2025.10.006_bib0240","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1136\/jnnp.2002.007724","article-title":"The effect of immunomodulatory treatment on multiple sclerosis fatigue","volume":"75","author":"Metz","year":"2004","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"3\u20134","key":"10.1016\/j.nrleng.2025.10.006_bib0245","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1159\/000111876","article-title":"Prevalence and severity of multiple-sclerosis-associated fatigue in treated and untreated patients","volume":"59","author":"Putzki","year":"2008","journal-title":"Eur Neurol"},{"issue":"11","key":"10.1016\/j.nrleng.2025.10.006_bib0250","doi-asserted-by":"crossref","first-page":"3235","DOI":"10.1007\/s10072-020-04367-9","article-title":"A snapshot on patient-reported outcome measures of people with multiple sclerosis on first-line therapies in a real world setting","volume":"41","author":"Lanzillo","year":"2020","journal-title":"Neurol Sci"},{"key":"10.1016\/j.nrleng.2025.10.006_bib0255","doi-asserted-by":"crossref","first-page":"S37","DOI":"10.1016\/S0022-510X(09)70011-5","article-title":"Multiple sclerosis beyond EDSS: depression and fatigue","volume":"277 Suppl 1","author":"Ziemssen","year":"2009","journal-title":"J Neurol Sci"},{"issue":"7","key":"10.1016\/j.nrleng.2025.10.006_bib0260","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1001\/archneur.1996.00550070080014","article-title":"The measurement of fatigue in patients with multiple sclerosis. A multidimensional comparison with patients with chronic fatigue syndrome and healthy subjects","volume":"53","author":"Vercoulen","year":"1996","journal-title":"Arch Neurol"},{"key":"10.1016\/j.nrleng.2025.10.006_bib0265","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1191\/135245800678827572","article-title":"Modalities of fatigue in multiple sclerosis: correlation with clinical and biological factors","volume":"6","author":"Iriarte","year":"2000","journal-title":"Mult Scler"},{"issue":"11","key":"10.1016\/j.nrleng.2025.10.006_bib0270","doi-asserted-by":"crossref","first-page":"1466","DOI":"10.1007\/s00415-006-0247-3","article-title":"Fatigue in multiple sclerosis persists over time: a longitudinal study","volume":"253","author":"T\u00e9llez","year":"2006","journal-title":"J Neurol"},{"key":"10.1016\/j.nrleng.2025.10.006_bib0275","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1001\/archneur.1988.00520280085020","article-title":"Fatigue in multiple sclerosis","volume":"45","author":"Krupp","year":"1988","journal-title":"Arch Neurol"},{"issue":"5","key":"10.1016\/j.nrleng.2025.10.006_bib0280","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1177\/1352458517690821","article-title":"Validity of the Symbol Digit Modalities Test as a cognition performance outcome measure for multiple sclerosis","volume":"23","author":"Benedict","year":"2017","journal-title":"Mult Scler"},{"issue":"2","key":"10.1016\/j.nrleng.2025.10.006_bib0285","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/j.jval.2018.08.002","article-title":"Association between disability, cognition, fatigue, EQ-5D-3L domains, and utilities estimated with different Western European value sets in patients with multiple sclerosis","volume":"22","author":"Eriksson","year":"2019","journal-title":"Value Health"},{"key":"10.1016\/j.nrleng.2025.10.006_bib0290","doi-asserted-by":"crossref","DOI":"10.1016\/j.msard.2022.104138","article-title":"Delayed cognitive processing and treatment status quo bias in early-stage multiple sclerosis","volume":"68","author":"Saposnik","year":"2022","journal-title":"Mult Scler Relat Disord"},{"key":"10.1016\/j.nrleng.2025.10.006_bib0295","doi-asserted-by":"crossref","DOI":"10.1016\/j.jns.2021.117437","article-title":"Quality of life in multiple sclerosis is dominated by fatigue, disability and self-efficacy","volume":"426","author":"Young","year":"2021","journal-title":"J Neurol Sci"},{"key":"10.1016\/j.nrleng.2025.10.006_bib0300","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1191\/1352458505ms1204oa","article-title":"Factors related to employment status changes in individuals with multiple sclerosis","volume":"11","author":"Smith","year":"2005","journal-title":"Mult Scler"}],"container-title":["Neurolog\u00eda (English Edition)"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2173580825001014?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2173580825001014?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,5]],"date-time":"2025-11-05T02:16:28Z","timestamp":1762308988000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2173580825001014"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11]]},"references-count":60,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2025,11]]}},"alternative-id":["S2173580825001014"],"URL":"https:\/\/doi.org\/10.1016\/j.nrleng.2025.10.006","relation":{},"ISSN":["2173-5808"],"issn-type":[{"value":"2173-5808","type":"print"}],"subject":[],"published":{"date-parts":[[2025,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Impact of fatigue on quality of life in adults with multiple sclerosis","name":"articletitle","label":"Article Title"},{"value":"Neurolog\u00eda (English Edition)","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.nrleng.2025.10.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/j.nrl.2023.06.011","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Sociedad Espa\u00f1ola de Neurolog\u00eda. Published by Elsevier Espa\u00f1a, S.L.U.","name":"copyright","label":"Copyright"}]}}